Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.

West Pharmaceutical Services Inc. closed 42.45% short of its 52-week high of $372.79, which the company reached on May 3rd.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX – Research Report) and ...

A team of three Biomedical Engineering undergraduates from West Chester University (WCU) has taken first place in the ...

The stock's fall snapped a three-day winning streak.